H N Rosen
Overview
Explore the profile of H N Rosen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaze A, Rosen H, Paik J
Osteoporos Int
. 2017 Nov;
29(1):31-39.
PMID: 29098347
Introduction: Recent evidence suggests that the relationship between BMI and fracture risk may be site-specific. We conducted a systematic review and meta-analysis of prospective studies to investigate the association between...
2.
Rosen H, Parker R, Greenspan S, Iloputaife I, Bookman L, Chapin D, et al.
Calcif Tissue Int
. 2004 Feb;
74(5):415-23.
PMID: 14961215
Antiresorptive therapy is usually given in a fixed dose, and we hypothesized that some patients receiving standard doses of hormone replacement therapy (HRT) might benefit from a higher dose, particularly...
3.
Greenspan S, Rosen H, Parker R
J Clin Endocrinol Metab
. 2000 Nov;
85(10):3537-40.
PMID: 11061497
The aim of this study was to determine whether early changes in serum markers of bone resorption could predict long-term responses in bone mineral density (BMD) after alendronate therapy in...
4.
Rosen H, Moses A, Garber J, Iloputaife I, Ross D, Lee S, et al.
Calcif Tissue Int
. 2000 Feb;
66(2):100-3.
PMID: 10652955
Serum CrossLaps is a new assay for measuring carboxy-terminal collagen crosslinks (CTX) in serum. This measurement is reported to be more specific to bone resorption than other measurements. However, the...
5.
Feskanich D, Korrick S, Greenspan S, Rosen H, Colditz G
J Womens Health
. 1999 Mar;
8(1):65-73.
PMID: 10094083
Chronic alcohol abuse is associated with low bone density and high risk of fracture. However, moderate alcohol consumption may help to maintain bone density in postmenopausal women by increasing endogenous...
6.
Rosen H, Moses A, Garber J, Ross D, Lee S, Greenspan S
Calcif Tissue Int
. 1998 Nov;
63(5):363-8.
PMID: 9799818
Biochemical markers of bone turnover are often measured in patients treated with antiresorptive agents to monitor the effects of therapy. In order for a change in these markers to clearly...
7.
Greenspan S, Parker R, Ferguson L, Rosen H, Karpf D
J Bone Miner Res
. 1998 Sep;
13(9):1431-8.
PMID: 9738515
Although the antiresorptive agent alendronate has been shown to increase bone mineral density (BMD) at the hip and spine and decrease the incidence of osteoporotic fractures in older women, few...
8.
Rosen H, Moses A, Garber J, Ross D, Lee S, Ferguson L, et al.
J Clin Endocrinol Metab
. 1998 Jul;
83(7):2324-30.
PMID: 9661603
Patients taking suppressive doses of T4 are thought to have accelerated bone loss and increased risk of osteoporosis. We therefore randomize 55 patients taking suppressive doses of T4 to treatment...
9.
Rosen H, Lim M, Garber J, Moreau S, Bhargava H, Pallotta J, et al.
Calcif Tissue Int
. 1998 Feb;
61(6):455-9.
PMID: 9383271
BIM-44002, a pure competitive antagonist of parathyroid hormone (PTH), has a high affinity for the PTH/PTHrP receptor in vitro, and can completely inhibit the actions of a PTH agonist in...
10.
Mantzoros C, Rosen H, Greenspan S, Flier J, Moses A
J Clin Endocrinol Metab
. 1997 Feb;
82(2):497-9.
PMID: 9024243
Leptin, a 16-kDa adipocyte-derived protein whose circulating levels reflect energy stores, increases the resting metabolic rate and thermogenesis in rodents. Thyroid hormones also increase the basal metabolic rate, but nothing...